PhD. Ph. Nguyen Khoa Dieu Hang, CEO of DongDo pharmaceutical company limited
1. Overview of development of Biosimilar.
Indicator: Ph. Nguyen Thi Thanh Huong, Head of Product Development Department, DongDo pharmaceutical company limited.
2. The utilization of rDNA Bioproducts – A major challenge.
Indicator: PhD.Ph. Hoang Thi Kim Huyen, Head of Clinic Pharmaceutical Department, Hanoi University of Pharmacy.
3. Evaluation of effectiveness and influential factors to Epokine effect in treating anemia of patients with periodic dialysis.
Indicator: PhD. Doc. Nguyen Cao Luan – Bach Mai Hospital.